clinical trials retatrutide peptide Retatrutide, the next generation of GLP-1 drug from Eli Lilly, helped Phase 2 Trial

Retatrutide data on this point is still being collected through the TRIUMPH maintenance arms

There is zero justification for reusing them

However, as clinicians celebrate these advances, a Read More Beyond the FIB-4: Why Diabetes Care Is Becoming a Hepatology-Endocrinology Partnership May 20, 2026 Articles, Diabetes, Gastroenterology, Obesity, Obesity, Type 2 Diabetes, Type 2 Diabetes 1,754 views Screening for fatty liver disease in patients with diabetes is no longer limited to identifying elevated liver enzymes or calculating a fibrosis score during an annual visit

To resolve this issue, the researchers investigated whether anti-obesity probiotic strains could enhance weight loss from GLP-1 drugs and decrease weight regain

Add too little and you risk not fully dissolving the peptide, leaving some stuck to the vial walls

Fat loss results require ongoing treatment and healthy lifestyle modifications